PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
4.46M / 3.59M (Avg.)
-1.65 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.77%
5Y revenue/share CAGR under 50% of YAL.AX's 43.43%. Michael Burry would suspect a significant competitive gap or product weakness.
2.46%
3Y revenue/share CAGR under 50% of YAL.AX's 138.69%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
359.87%
10Y OCF/share CAGR above 1.5x YAL.AX's 147.40%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-33.91%
Negative 5Y OCF/share CAGR while YAL.AX is at 9.30%. Joel Greenblatt would question the firm’s operational model or cost structure.
138.76%
3Y OCF/share CAGR under 50% of YAL.AX's 1015.09%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
29.54%
Below 50% of YAL.AX's 121.13%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
957.27%
5Y net income/share CAGR above 1.5x YAL.AX's 64.91%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
298.41%
3Y net income/share CAGR above 1.5x YAL.AX's 151.43%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-89.86%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
209.87%
5Y equity/share CAGR above 1.5x YAL.AX's 38.41%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
1153.54%
3Y equity/share CAGR above 1.5x YAL.AX's 62.59%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6126955.88%
3Y dividend/share CAGR of 6126955.88% while YAL.AX is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.